TAMPA, Fla.--(BUSINESS WIRE)--As Neutra Corp. (OTCBB: NTRR) and its joint venture partner, Surface to Air Solutions (S2O2), continue working to add to their growing list of horticultural clients, the pace of expansion in the U.S. cannabis industry remains unprecedented. Last week, medicinal cannabis was sold for the first time in Nevada, 15 years after the state’s citizens voted to legalize it.
The long-awaited opening of the Silver State’s first dispensary was celebrated by a cheering crowd on Friday in Reno. It was a major step forward for the cannabis industry in Nevada, one of 23 states that allow medicinal cannabis sales.
For NTRR, Nevada represents an important new market in its mission to deliver new horticultural products to indoor farmers in a rapidly rising industry. Alongside S2O2, NTRR is marketing a suite of products carefully engineered to help prevent the buildup of mold, powdery mildew, and botrytis on plants, surfaces and air inside growing facilities without the use of potentially harmful chemicals. The joint venture already counts multiple major growing operations in the U.S. and Canada as clients, and is actively engaged in talks to branch out into new markets across North America.
“The people of Nevada demanded the right to dispensaries from their government, and Friday’s grand opening was just the start,” said NTRR CEO Chris Brown. “We know from our market research across North America that consumers want access to safe, predictable cannabis products that have not been contaminated by pests or harsh chemicals, and dispensary owners know it, too. That’s why we’re having so much success convincing growers to give our product suite a try.”
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.